{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:24:53Z","timestamp":1792664693734,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12022-025-09852-5","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T08:47:52Z","timestamp":1742287672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Refining NTRK Fusion Detection in Papillary Thyroid Carcinoma Through Pan-TRK Immunohistochemistry and Histopathologic Features"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7005-8142","authenticated-orcid":false,"given":"Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0279-9787","authenticated-orcid":false,"given":"Sue Youn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-0418","authenticated-orcid":false,"given":"Ji Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1128-892X","authenticated-orcid":false,"given":"Seung-Hyun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2801","authenticated-orcid":false,"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6843-3708","authenticated-orcid":false,"given":"Chan Kwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"3","key":"9852_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.7150\/ijms.29935","volume":"16","author":"MI Abdullah","year":"2019","unstructured":"Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH. Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations. Int J Med Sci. 2019;16(3):450-60. https:\/\/doi.org\/10.7150\/ijms.29935.","journal-title":"Int J Med Sci."},{"issue":"1","key":"9852_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/ep:13:1:03","volume":"13","author":"YE Nikiforov","year":"2002","unstructured":"Nikiforov YE. RET\/PTC rearrangement in thyroid tumors. Endocr Pathol. 2002;13(1):3-16. https:\/\/doi.org\/10.1385\/ep:13:1:03.","journal-title":"Endocr Pathol."},{"key":"9852_CR3","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research N. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159(3):676\u201390. https:\/\/doi.org\/10.1016\/j.cell.2014.09.050.","DOI":"10.1016\/j.cell.2014.09.050"},{"issue":"23","key":"9852_CR4","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1158\/1078-0432.CCR-18-1156","volume":"24","author":"ES Kheder","year":"2018","unstructured":"Kheder ES, Hong DS. Emerging Targeted Therapy for Tumors with NTRK Fusion Proteins. Clin Cancer Res. 2018;24(23):5807-14. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1156.","journal-title":"Clin Cancer Res."},{"issue":"8","key":"9852_CR5","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaoncol.2023.1379","volume":"9","author":"R Haddad","year":"2023","unstructured":"Haddad R, Elisei R, Hoff AO, Liu Z, Pitoia F, Pruneri G, et al. Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review. JAMA Oncol. 2023;9(8):1132-41. https:\/\/doi.org\/10.1001\/jamaoncol.2023.1379.","journal-title":"JAMA Oncol."},{"issue":"4","key":"9852_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s12022-022-09739-9","volume":"33","author":"YH Chu","year":"2022","unstructured":"Chu YH, Sadow PM. Kinase Fusion-Related Thyroid Carcinomas: Towards Predictive Models for Advanced Actionable Diagnostics. Endocr Pathol. 2022;33(4):421-35. https:\/\/doi.org\/10.1007\/s12022-022-09739-9.","journal-title":"Endocr Pathol."},{"issue":"4","key":"9852_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12022-024-09836-x","volume":"35","author":"O Mete","year":"2024","unstructured":"Mete O, Boucher A, Schrader KA, Abdel-Rahman O, Bahig H, Ho C, et al. Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management. Endocr Pathol. 2024;35(4):293-308. https:\/\/doi.org\/10.1007\/s12022-024-09836-x.","journal-title":"Endocr Pathol."},{"key":"9852_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102380","volume":"106","author":"J Capdevila","year":"2022","unstructured":"Capdevila J, Awada A, Fuhrer-Sakel D, Leboulleux S, Pauwels P. Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era. Cancer Treat Rev. 2022;106:102380. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102380.","journal-title":"Cancer Treat Rev."},{"issue":"3","key":"9852_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.32074\/1591-951X-787","volume":"114","author":"A Marchetti","year":"2022","unstructured":"Marchetti A, Ferro B, Pasciuto MP, Zampacorta C, Buttitta F, D'Angelo E. NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies. Pathologica. 2022;114(3):199-216. https:\/\/doi.org\/10.32074\/1591-951X-787.","journal-title":"Pathologica."},{"key":"9852_CR10","doi-asserted-by":"publisher","unstructured":"Pekova B, Sykorova V, Mastnikova K, Vaclavikova E, Moravcova J, Vlcek P, et al. NTRK Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis. Cancers (Basel). 2021;13(8). https:\/\/doi.org\/10.3390\/cancers13081932.","DOI":"10.3390\/cancers13081932"},{"issue":"2","key":"9852_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12022-023-09764-2","volume":"34","author":"JC Slack","year":"2023","unstructured":"Slack JC, Hollowell M, Barletta JA. Thyroid Nodules and Follicular Cell-Derived Thyroid Carcinomas in Children. Endocr Pathol. 2023;34(2):165-75. https:\/\/doi.org\/10.1007\/s12022-023-09764-2.","journal-title":"Endocr Pathol."},{"issue":"11","key":"9852_CR12","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","volume":"41","author":"JF Hechtman","year":"2017","unstructured":"Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, et al. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions. Am J Surg Pathol. 2017;41(11):1547-51. https:\/\/doi.org\/10.1097\/PAS.0000000000000911.","journal-title":"Am J Surg Pathol."},{"issue":"9","key":"9852_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","volume":"30","author":"C Marchio","year":"2019","unstructured":"Marchio C, Scaltriti M, Ladanyi M, Iafrate AJ, Bibeau F, Dietel M, et al. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. Ann Oncol. 2019;30(9):1417-27. https:\/\/doi.org\/10.1093\/annonc\/mdz204.","journal-title":"Ann Oncol."},{"issue":"4","key":"9852_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12022-020-09648-9","volume":"31","author":"YC Lee","year":"2020","unstructured":"Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF. Detection of NTRK1\/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing. Endocr Pathol. 2020;31(4):348-58. https:\/\/doi.org\/10.1007\/s12022-020-09648-9.","journal-title":"Endocr Pathol."},{"issue":"4","key":"9852_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1530\/EJE-20-1345","volume":"184","author":"Y Kong","year":"2021","unstructured":"Kong Y, Bu R, Parvathareddy SK, Siraj AK, Siraj N, Al-Sobhi SS, et al. NTRK fusion analysis reveals enrichment in Middle Eastern BRAF wild-type PTC. Eur J Endocrinol. 2021;184(4):503-11. https:\/\/doi.org\/10.1530\/EJE-20-1345.","journal-title":"Eur J Endocrinol."},{"key":"9852_CR16","doi-asserted-by":"publisher","unstructured":"Lee SE, Lee MS, Bang H, Kim MY, Choi YL, Oh YL. NTRK Fusion in a Cohort of BRAF p. V600E Wild-Type Papillary Thyroid Carcinomas. Mod Pathol. 2023;36(8):100180. https:\/\/doi.org\/10.1016\/j.modpat.2023.100180.","DOI":"10.1016\/j.modpat.2023.100180"},{"issue":"3","key":"9852_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41379-021-00913-8","volume":"35","author":"JF Hechtman","year":"2022","unstructured":"Hechtman JF. NTRK insights: best practices for pathologists. Mod Pathol. 2022;35(3):298-305. https:\/\/doi.org\/10.1038\/s41379-021-00913-8.","journal-title":"Mod Pathol."},{"issue":"4","key":"9852_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4132\/jptm.2020.05.12","volume":"54","author":"SY Kim","year":"2020","unstructured":"Kim SY, Kim T, Kim K, Bae JS, Kim JS, Jung CK. Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans. J Pathol Transl Med. 2020;54(4):310-7. https:\/\/doi.org\/10.4132\/jptm.2020.05.12.","journal-title":"J Pathol Transl Med."},{"issue":"1","key":"9852_CR19","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5.","journal-title":"Sci Rep."},{"issue":"2","key":"9852_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4132\/jptm.2024.01.23","volume":"58","author":"YA Liu","year":"2024","unstructured":"Liu YA, Aung PP, Wang Y, Ning J, Nagarajan P, Curry JL, et al. TRPS1 expression in non-melanocytic cutaneous neoplasms: an immunohistochemical analysis of 200 cases. J Pathol Transl Med. 2024;58(2):72-80. https:\/\/doi.org\/10.4132\/jptm.2024.01.23.","journal-title":"J Pathol Transl Med."},{"issue":"6","key":"9852_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4132\/jptm.2023.10.12","volume":"57","author":"DH Lee","year":"2023","unstructured":"Lee DH, Jeong IH, Jang B. Elevated expression of Axin2 in intestinal metaplasia and gastric cancers. J Pathol Transl Med. 2023;57(6):315-22. https:\/\/doi.org\/10.4132\/jptm.2023.10.12.","journal-title":"J Pathol Transl Med."},{"issue":"3","key":"9852_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s12022-021-09688-9","volume":"32","author":"JS Bae","year":"2021","unstructured":"Bae JS, Jung SH, Hirokawa M, Bychkov A, Miyauchi A, Lee S, et al. High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid. Endocr Pathol. 2021;32(3):336-46. https:\/\/doi.org\/10.1007\/s12022-021-09688-9.","journal-title":"Endocr Pathol."},{"issue":"3","key":"9852_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174737","volume":"12","author":"Y Kim","year":"2017","unstructured":"Kim Y, Kim MH, Jeon S, Kim J, Kim C, Bae JS, et al. Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma. PLoS One. 2017;12(3):e0174737. https:\/\/doi.org\/10.1371\/journal.pone.0174737.","journal-title":"PLoS One."}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-025-09852-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-025-09852-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-025-09852-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:25:37Z","timestamp":1767860737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-025-09852-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9852"],"URL":"https:\/\/doi.org\/10.1007\/s12022-025-09852-5","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"6 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Seoul St. Mary\u2019s Hospital (KC16SISI0104), College of Medicine, The Catholic University of Korea. Informed consent was waived by the board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was waived by the institutional review board because of the retrospective nature of this study, which used anonymous clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors approved for the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7"}}